-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Reiterates Buy on Arrowhead Pharma, Maintains $100 Price Target

Benzinga·03/25/2026 17:30:19
Listen to the news
HC Wainwright & Co. analyst Patrick R. Trucchio reiterates Arrowhead Pharma (NASDAQ:ARWR) with a Buy and maintains $100 price target.